FDA approves the Flexichamber collapsible valved holding chamber

FSC Laboratories has announced that its Flexichamber collapsible valved holding chamber has received FDA clearance for use with most pMDIs. The device, which can be used with or without a mask, will be available by prescription only and will be distributed by FSC Pediatrics.

FSC Pediatrics President and CEO Peter W. Steelman commented, “We developed Flexichamber, a patented, compact collapsible holding chamber, to address pediatric patient and parent needs by combining the clinical effectiveness expected from the leading hard-sided chambers and the convenience of a device that can easily fit in a pocket, backpack, or purse.”

Read the FSC Laboratories press release.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan